LT4843B - Enterine danga padengta farmacinė kompozicija ir jos pagaminimo būdas - Google Patents

Enterine danga padengta farmacinė kompozicija ir jos pagaminimo būdas Download PDF

Info

Publication number
LT4843B
LT4843B LT2000105A LT2000105A LT4843B LT 4843 B LT4843 B LT 4843B LT 2000105 A LT2000105 A LT 2000105A LT 2000105 A LT2000105 A LT 2000105A LT 4843 B LT4843 B LT 4843B
Authority
LT
Lithuania
Prior art keywords
pharmaceutical composition
granules
drug
weight
coating
Prior art date
Application number
LT2000105A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2000105A (en
Inventor
Ismat Ullah
Gary J. Wiley
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22179393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4843(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of LT2000105A publication Critical patent/LT2000105A/xx
Publication of LT4843B publication Critical patent/LT4843B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LT2000105A 1998-05-22 2000-11-07 Enterine danga padengta farmacinė kompozicija ir jos pagaminimo būdas LT4843B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8359798A 1998-05-22 1998-05-22

Publications (2)

Publication Number Publication Date
LT2000105A LT2000105A (en) 2001-04-25
LT4843B true LT4843B (lt) 2001-09-25

Family

ID=22179393

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2000105A LT4843B (lt) 1998-05-22 2000-11-07 Enterine danga padengta farmacinė kompozicija ir jos pagaminimo būdas

Country Status (40)

Country Link
US (2) US6224910B1 (ko)
EP (1) EP1079809B1 (ko)
JP (2) JP3798625B2 (ko)
KR (1) KR100484299B1 (ko)
CN (1) CN1149075C (ko)
AP (1) AP1206A (ko)
AR (1) AR017747A1 (ko)
AT (2) ATE311859T1 (ko)
AU (1) AU750911B2 (ko)
BG (1) BG65398B1 (ko)
BR (1) BR9815861A (ko)
CA (1) CA2332922C (ko)
CO (1) CO5070679A1 (ko)
CY (1) CY1119543T1 (ko)
CZ (1) CZ300497B6 (ko)
DE (2) DE1079809T1 (ko)
DK (2) DK1079809T3 (ko)
DZ (1) DZ2797A1 (ko)
EE (1) EE04926B1 (ko)
ES (1) ES2165833T3 (ko)
GE (1) GEP20033014B (ko)
HK (1) HK1034461A1 (ko)
HU (1) HU226491B1 (ko)
ID (1) ID27031A (ko)
IL (1) IL139274A (ko)
LT (1) LT4843B (ko)
LV (1) LV12602B (ko)
MA (1) MA26636A1 (ko)
NO (2) NO322903B1 (ko)
NZ (1) NZ508194A (ko)
OA (1) OA11512A (ko)
PL (1) PL193294B1 (ko)
RO (1) RO121674B1 (ko)
RU (1) RU2197227C2 (ko)
SK (1) SK284890B6 (ko)
TN (1) TNSN99097A1 (ko)
TR (1) TR200003373T2 (ko)
UA (1) UA69413C2 (ko)
WO (1) WO1999061002A1 (ko)
ZA (1) ZA993090B (ko)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
PE20000601A1 (es) 1998-03-23 2000-07-25 Gen Mills Inc Encapsulado de componentes en productos comestibles
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
WO2002038133A2 (en) * 2000-11-10 2002-05-16 F. Hoffman-La Roche Ag Compositions containing hydrolytically unstable compounds
US6821445B2 (en) * 2001-04-04 2004-11-23 Ngk Insulators, Ltd. Rainwater-treating apparatus in combined sewer system and backwashing method therefor
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
EP1429742B1 (en) * 2001-09-28 2011-05-04 McNeil-PPC, Inc. Modified release dosage forms
EP1905431A1 (en) * 2002-01-11 2008-04-02 Circ Pharma Research and Development Limited Pravastatin pharmaceutical formulations and methods of their use
WO2003057195A1 (en) * 2002-01-11 2003-07-17 Athpharma Limited Pravastatin pharmaceutical formulations and methods of their use
EP2543385A1 (en) * 2002-01-21 2013-01-09 NRL Pharma, Inc. Novel analgesics
EA200401227A1 (ru) * 2002-03-22 2005-04-28 Рэнбакси Лабораториз Лимитед Система доставки лекарства с контролируемым высвобождением, включающая правастатин
US20040028737A1 (en) * 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
EP2033631A3 (en) * 2002-09-03 2009-06-03 Circ Pharma Research and Development Limited Pravastatin pharmaceutical formulations and methods of their use
WO2004021972A2 (en) * 2002-09-03 2004-03-18 Biovail Laboratories, Inc. Pharmaceuticals formulations and methods for modified release of statin drugs
CA2520321A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
CN100415211C (zh) * 2003-07-03 2008-09-03 上海现代药物制剂工程研究中心 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法
EP1694300A4 (en) * 2003-12-09 2009-04-29 Pharmasset Inc DOSAGE PROCESS FOR BETA-D-2 ', 3'-DIDEOXY-2', 3'-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
RU2381813C2 (ru) * 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
KR20070084325A (ko) * 2004-11-18 2007-08-24 브리스톨-마이어스 스큅 컴퍼니 익사베필론을 포함하는 장용성 코팅된 비드 및 그의 제조방법
WO2006054175A2 (en) * 2004-11-18 2006-05-26 Aurobindo Pharma Limited Stable dosage forms of acid labile drug
US20060134214A1 (en) * 2004-11-18 2006-06-22 Ismat Ullah Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US11744803B2 (en) 2005-07-29 2023-09-05 Stichting Groningen Centre for Drug Rese PH-controlled pulsatile delivery system, methods for preparation and use thereof
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
BRPI0614545B8 (pt) 2005-08-15 2021-05-25 Abbott Products Gmbh composição farmacêutica de liberação controlada, seu processo de produção, forma de dosagem oral com revestimento entérico de pacreatina e uso da mesma
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007072060A2 (en) * 2005-12-23 2007-06-28 Cipla Limited Particles comprising a core containing a hmg-coa reductase inhibitor and coated with a film
SI2535044T1 (sl) 2006-01-27 2020-06-30 The Regents Of The University Of California Cisteamin bitartrat in cistamin z enterično oblogo
WO2007109244A2 (en) * 2006-03-21 2007-09-27 Morehouse School Of Medicine Novel nanoparticles for delivery of active agents
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
ES2331501B1 (es) * 2007-11-14 2010-10-21 Blanver Farmoquimica, Ltda Composicion farmaceutica solida de didanosina.
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
PT2276485E (pt) 2008-04-24 2014-10-20 Bristol Myers Squibb Co Utilização de epotilona d no tratamento de doenças tauassociadas que compreendem a doença de alzheimer
US20100221329A1 (en) 2008-12-03 2010-09-02 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
JP6393037B2 (ja) 2010-09-15 2018-09-19 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃアゴニストの製剤および使用方法
GB2484929A (en) 2010-10-25 2012-05-02 Maria Christiana Peter Geraedts An edible product including plant protein
KR20120135063A (ko) * 2011-06-01 2012-12-12 닛토덴코 가부시키가이샤 입자 제제 및 그 제조 방법
US10117447B1 (en) * 2013-03-15 2018-11-06 The United States Of America, As Represented By The Secretary Of Agriculture Extrusion of high density hydroxypropylmethylcellulose edible flexible gels
AR096628A1 (es) 2013-06-17 2016-01-20 Raptor Pharmaceuticals Inc Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella
CN104758180A (zh) * 2014-01-06 2015-07-08 山东诚创医药技术开发有限公司 一种复方制剂胶囊的二次填充方法
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
WO2017040864A1 (en) 2015-09-01 2017-03-09 First Wave Biopharma Methods and compositions for treating conditions associated with an abnormal inflammatory responses
US10143665B2 (en) 2015-11-17 2018-12-04 Horizon Orphan Llc Methods for storing cysteamine formulations and related methods of treatment
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения
EP3630171A1 (en) 2017-05-26 2020-04-08 Animal Microbiome Analytics, Inc. Products and methods for therapeutic administration of microorganisms to non-human animals
KR20210043779A (ko) * 2019-10-11 2021-04-22 넨시스(주) 판크레아틴 장용코팅 펠릿 제조방법
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809918A (en) 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
US3835221A (en) 1970-03-05 1974-09-10 Hoechst Ag Orally administrable drug dosage form having delayed action
US4728512A (en) 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US4861759A (en) 1985-08-26 1989-08-29 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions and methods
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5254539A (en) 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5536507A (en) 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
ZA822995B (en) 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4556552A (en) 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
US4704295A (en) 1983-09-19 1987-11-03 Colorcon, Inc. Enteric film-coating compositions
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4775536A (en) 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2643222B2 (ja) 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US4925675A (en) 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US5026559A (en) 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
PH30058A (en) * 1989-11-24 1996-11-08 Biochemie Gmbh Pancreation preparations
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US5175003A (en) 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5350584A (en) 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
SG42869A1 (en) 1992-08-05 1997-10-17 Faulding F H & Co Ltd Pelletised pharmaceutical composition
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
IT1265074B1 (it) * 1993-05-18 1996-10-30 Istituto Biochimico Italiano Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
US5789014A (en) 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809918A (en) 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
US3835221A (en) 1970-03-05 1974-09-10 Hoechst Ag Orally administrable drug dosage form having delayed action
US4728512A (en) 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4861759A (en) 1985-08-26 1989-08-29 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions and methods
US5254539A (en) 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5616566A (en) 1985-08-26 1997-04-01 The United States Of America As Represented By The Department Of Health And Human Services Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5536507A (en) 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
F. W. GOODHART ET AL.: "An evaluation of aqueous film-forming dispersions for controlled release", PHARM TECH., 1984, pages 64 - 71

Also Published As

Publication number Publication date
LV12602B (en) 2001-07-20
TR200003373T2 (tr) 2001-03-21
US20010005716A1 (en) 2001-06-28
DZ2797A1 (fr) 2003-12-01
NO20062106L (no) 1999-11-23
HUP0101714A3 (en) 2002-10-28
CZ300497B6 (cs) 2009-06-03
PL344259A1 (en) 2001-10-22
ES2165833T1 (es) 2002-04-01
AT6311U1 (de) 2003-08-25
NO20005879D0 (no) 2000-11-21
OA11512A (en) 2004-02-03
NO20005879L (no) 2001-01-18
CZ20004362A3 (en) 2001-05-16
CO5070679A1 (es) 2001-08-28
AP2000001988A0 (en) 2000-12-31
JP3798625B2 (ja) 2006-07-19
ES2165833T3 (es) 2006-05-16
CY1119543T1 (el) 2018-04-04
BG105061A (en) 2001-07-31
WO1999061002A1 (en) 1999-12-02
IL139274A0 (en) 2001-11-25
TNSN99097A1 (fr) 2005-11-10
LV12602A (en) 2001-01-20
SK16302000A3 (sk) 2001-08-06
ID27031A (id) 2001-02-22
AU8685498A (en) 1999-12-13
AR017747A1 (es) 2001-10-24
JP2006022115A (ja) 2006-01-26
CA2332922A1 (en) 1999-12-02
HK1034461A1 (en) 2001-10-26
IL139274A (en) 2004-12-15
HU226491B1 (en) 2009-03-02
NO322903B1 (no) 2006-12-18
EP1079809A4 (en) 2001-11-07
DK1079809T3 (da) 2006-02-20
GEP20033014B (en) 2003-07-25
RU2197227C2 (ru) 2003-01-27
CN1294509A (zh) 2001-05-09
BG65398B1 (bg) 2008-06-30
AU750911B2 (en) 2002-08-01
UA69413C2 (uk) 2004-09-15
CN1149075C (zh) 2004-05-12
JP2002516268A (ja) 2002-06-04
MA26636A1 (fr) 2004-12-20
AP1206A (en) 2003-09-18
DE69832731T2 (de) 2006-09-14
KR100484299B1 (ko) 2005-04-20
BR9815861A (pt) 2001-01-16
LT2000105A (en) 2001-04-25
PL193294B1 (pl) 2007-01-31
DE69832731D1 (de) 2006-01-12
EE04926B1 (et) 2007-12-17
EP1079809B1 (en) 2005-12-07
US6224910B1 (en) 2001-05-01
KR20010043736A (ko) 2001-05-25
EP1079809A1 (en) 2001-03-07
SK284890B6 (sk) 2006-02-02
DK200200229U3 (da) 2003-01-24
HUP0101714A2 (hu) 2002-01-28
NZ508194A (en) 2003-07-25
CA2332922C (en) 2008-02-12
EE200000680A (et) 2002-10-15
ZA993090B (en) 2000-11-06
RO121674B1 (ro) 2008-02-28
ATE311859T1 (de) 2005-12-15
DE1079809T1 (de) 2002-08-22

Similar Documents

Publication Publication Date Title
LT4843B (lt) Enterine danga padengta farmacinė kompozicija ir jos pagaminimo būdas
US20010024660A1 (en) Enteric coated pharmaceutical composition and method of manufacturing
US7122207B2 (en) High drug load acid labile pharmaceutical composition
EP1098635B1 (en) Enteric coated pharmaceutical tablet containing didanosine
MXPA00010963A (en) Enteric coated pharmaceutical composition and method of manufacturing

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20180804